Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Mariska Vos"'
Autor:
Chantal Kroone, Mariska Vos, Timo Rademakers, Marijke Kuijpers, Mark Hoogenboezem, Jaap van Buul, Johan W.M. Heemskerk, Wolfram Ruf, Astrid van Hylckama Vlieg, Henri H. Versteeg, Marie-José Goumans, Carlie J.M. de Vries, Kondababu Kurakula, INVENT Consortium
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
Bleeding disorders and thrombotic complications are major causes of morbidity and mortality with many cases being unexplained. Thrombus formation involves aberrant expression and activation of tissue factor (TF) in vascular endothelial and smooth mus
Externí odkaz:
https://doaj.org/article/641ed4c9f0bc46ff9923379992fff131
Autor:
Kondababu Kurakula, Duco S. Koenis, Mark A. Herzik, Yanyun Liu, John W. Craft, Pieter B. van Loenen, Mariska Vos, M. Khang Tran, Henri H. Versteeg, Marie-José T.H. Goumans, Wolfram Ruf, Carlie J.M. de Vries, Mehmet Şen
Publikováno v:
Haematologica, Vol 103, Iss 6 (2018)
Tissue Factor is a cell-surface glycoprotein expressed in various cells of the vasculature and is the principal regulator of the blood coagulation cascade and hemostasis. Notably, aberrant expression of Tissue Factor is associated with cardiovascular
Externí odkaz:
https://doaj.org/article/f24af6fdbd004558a55a651fb28171cf
Autor:
Gijs H M van Puijvelde, Amanda C Foks, Rosemarie E van Bochove, Ilze Bot, Kim L L Habets, Saskia C de Jager, Mariëtte N D Ter Borg, Puck van Osch, Louis Boon, Mariska Vos, Vivian de Waard, Johan Kuiper
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190962 (2018)
An abdominal aortic aneurysm (AAA) is a dilatation of the abdominal aorta leading to serious complications and mostly to death. AAA development is associated with an accumulation of inflammatory cells in the aorta including NKT cells. An important fa
Externí odkaz:
https://doaj.org/article/2ef143ea6d7b40768aea73f7394d8ed1
Autor:
Thijs W H Pols, Teresa Puchner, H Inci Korkmaz, Mariska Vos, Maarten R Soeters, Carlie J M de Vries
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176715 (2017)
Bile acids are established signaling molecules next to their role in the intestinal emulsification and uptake of lipids. We here aimed to identify a potential interaction between bile acids and CD4+ Th cells, which are central in adaptive immune resp
Externí odkaz:
https://doaj.org/article/ea3e342f404245548b1732c20e8621b8
Autor:
Anouk A J Hamers, Laura van Dam, José M Teixeira Duarte, Mariska Vos, Goran Marinković, Claudia M van Tiel, Sybren L Meijer, Anne-Marieke van Stalborch, Stephan Huveneers, Anje A Te Velde, Wouter J de Jonge, Carlie J M de Vries
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0133598 (2015)
Nuclear receptor Nur77, also referred to as NR4A1 or TR3, plays an important role in innate and adaptive immunity. Nur77 is crucial in regulating the T helper 1/regulatory T-cell balance, is expressed in macrophages and drives M2 macrophage polarizat
Externí odkaz:
https://doaj.org/article/4b9b9f329923409a8e16c7fe047764c6
Autor:
Kondababu Kurakula, Mariska Vos, Iker Otermin Rubio, Goran Marinković, Reinhard Buettner, Lukas C Heukamp, Jan Stap, Vivian de Waard, Claudia M van Tiel, Carlie J M de Vries
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94931 (2014)
The LIM-only protein FHL2, also known as DRAL or SLIM3, has a function in fine-tuning multiple physiological processes. FHL2 is expressed in the vessel wall in smooth muscle cells (SMCs) and endothelial cells and conflicting data have been reported o
Externí odkaz:
https://doaj.org/article/26b213cef63945599aa7e3cec543a1a3
Autor:
Jayron J. Habibe, Maria P. Clemente-Olivo, Torsten P. M. Scheithauer, Elena Rampanelli, Hilde Herrema, Mariska Vos, Arnout Mieremet, Max Nieuwdorp, Daniel H. van Raalte, Etto C. Eringa, Carlie J. M. de Vries
Publikováno v:
Diabetologia, 65(10):s00125-022-05750-1, 1721-1733. Springer, Cham
Diabetologia, 65(10), 1721-1733. Springer Verlag
Habibe, J J, Clemente-Olivo, M P, Scheithauer, T P M, Rampanelli, E, Herrema, H, Vos, M, Mieremet, A, Nieuwdorp, M, van Raalte, D H, Eringa, E C & de Vries, C J M 2022, ' Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes ', Diabetologia, vol. 65, no. 10, pp. 1721-1733 . https://doi.org/10.1007/s00125-022-05750-1
Diabetologia, 65(10), 1721-1733. Springer Verlag
Habibe, J J, Clemente-Olivo, M P, Scheithauer, T P M, Rampanelli, E, Herrema, H, Vos, M, Mieremet, A, Nieuwdorp, M, van Raalte, D H, Eringa, E C & de Vries, C J M 2022, ' Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes ', Diabetologia, vol. 65, no. 10, pp. 1721-1733 . https://doi.org/10.1007/s00125-022-05750-1
Aims/hypothesis The general population is ageing, involving an enhanced incidence of chronic diseases such as type 2 diabetes. With ageing, DNA methylation of FHL2 increases, as well as expression of the four and a half LIM domains 2 (FHL2) protein i
Autor:
Patrick C.N. Rensen, Carlie J.M. de Vries, Jayron J. Habibe, Sander Kooijman, Hilde Herrema, Mariska Vos, Maria P. Clemente-Olivo, Roelof Ottenhoff, Max Nieuwdorp, Noam Zelcer, Aldo Jongejan, Etto C. Eringa, Daniël H. van Raalte
Publikováno v:
Metabolism: clinical and experimental, 121:154815. W.B. Saunders Ltd
Clemente-Olivo, M P, Habibe, J J, Vos, M, Ottenhoff, R, Jongejan, A, Herrema, H, Zelcer, N, Kooijman, S, Rensen, P C N, van Raalte, D H, Nieuwdorp, M, Eringa, E C & de Vries, C J 2021, ' Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity ', Metabolism: Clinical and Experimental, vol. 121, 154815, pp. 1-14 . https://doi.org/10.1016/j.metabol.2021.154815
Metabolism
Metabolism: Clinical and Experimental, 121:154815, 1-14. W.B. Saunders Ltd
Metabolism, 121. W B SAUNDERS CO-ELSEVIER INC
Clemente-Olivo, M P, Habibe, J J, Vos, M, Ottenhoff, R, Jongejan, A, Herrema, H, Zelcer, N, Kooijman, S, Rensen, P C N, van Raalte, D H, Nieuwdorp, M, Eringa, E C & de Vries, C J 2021, ' Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity ', Metabolism: Clinical and Experimental, vol. 121, 154815, pp. 1-14 . https://doi.org/10.1016/j.metabol.2021.154815
Metabolism
Metabolism: Clinical and Experimental, 121:154815, 1-14. W.B. Saunders Ltd
Metabolism, 121. W B SAUNDERS CO-ELSEVIER INC
Objective: Four-and-a-Half-LIM-domain-protein 2 (FHL2) modulates multiple signal transduction pathways but has not been implicated in obesity or energy metabolism. In humans, methylation and expression of the FHL2 gene increases with age, and high FH
Autor:
Mariska Vos, Vivian de Waard, Ron Balm, Shaynah Wanga, Ingeborg van der Made, Stijntje Hibender, Carlie J.M. de Vries, Barbara J.M. Mulder
Publikováno v:
Cardiovascular pathology, 38, 1-6. Elsevier Inc.
Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the fibrillin-1 gene (FBN1), resulting in aortic aneurysm formation and dissections. Interestingly, variable aortopathy is observed even within MFS families with the same mu
Autor:
C. J. M. De Vries, Mariska Vos, Marco C. DeRuiter, V Van De Pol, Marie-José Goumans, Kondababu Kurakula
Publikováno v:
Vascular Pharmacology, 125. ELSEVIER SCIENCE INC
Vascular Pharmacology
Vascular Pharmacology, 125-126:106634. Elsevier Inc.
Vascular pharmacology. Elsevier Inc.
van de Pol, V, Vos, M, DeRuiter, M C, Goumans, M J, de Vries, C J M & Kurakula, K 2020, ' LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway ', Vascular Pharmacology, vol. 125-126, 106634 . https://doi.org/10.1016/j.vph.2019.106634
Vascular Pharmacology
Vascular Pharmacology, 125-126:106634. Elsevier Inc.
Vascular pharmacology. Elsevier Inc.
van de Pol, V, Vos, M, DeRuiter, M C, Goumans, M J, de Vries, C J M & Kurakula, K 2020, ' LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway ', Vascular Pharmacology, vol. 125-126, 106634 . https://doi.org/10.1016/j.vph.2019.106634
Despite the advent of new-generation drug-eluting stents, in-stent restenosis remains a significant problem in patients with coronary artery disease. In- stent restenosis is defined as the gradual re-narrowing of a stented coronary artery lesion due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64ef6d202fc1a017b47470059ae76787
https://doi.org/10.1016/j.vph.2019.106634
https://doi.org/10.1016/j.vph.2019.106634